Aurobindo Pharma Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
18.84 | 45.74 | -58.82% | 13.41 | +40.47% |
| P/S |
|
2.08 | 5.12 | -59.36% |
|
|
| P/BV |
|
2 | 6.3 | -68.22% |
|
|
| P/FCF |
|
-40.83 | 168.72 | -124.2% |
|
|
| Ev/Ebitda |
|
7.61 | 13.54 | -43.84% |
|
|
| Ev/S |
|
2.18 | 4.77 | -54.18% |
|
|
| Ev/FCF |
|
-55.63 | 163.7 | -133.99% |
|
|
| E/P |
|
0.069 | 0.0451 | 52.95% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
4/10
|
13.93 | 20.29 | -31.35% | 21.07 | -33.91% |
| ROE |
|
11.2 | 17.11 | -34.58% |
|
|
| ROA |
|
7.47 | 10.34 | -27.73% |
|
|
| ROIC |
|
6.91 | 10.89 | -36.51% |
|
|
| ROS |
|
11.05 | 11.98 | -7.77% |
|
|
| ROCE |
|
8.42 | 4.26 | 97.46% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
7/10
|
1.58 | 1.22 | 29.67% | 1.12 | +40.91% |
| Nеt Debt/Ebitda |
|
0.7309 | 1.06 | -30.95% |
|
|
| Debt/Ratio |
|
0.1401 | 0.1307 | 7.2% |
|
|
| Debt/Equity |
|
0.5056 | 0.7972 | -36.59% |
|
|
| Debt/Net Income |
|
1.99 | 3.19 | -37.65% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
1.83/10
|
0.7306 | 11.94 | -93.88% | 0.837 | -12.71% |
| Number of years of dividend growth |
|
0 | 1.26 | -100% | ||
| DSI |
|
0.8571 | 0.8503 | 0.8034% |
|
|
| Average dividend growth |
|
-6.1 | -63.65 | -90.42% |
|
|
| Average percentage for 5 years |
|
0.837 | 11.6 | -92.78% |
|
|
| Average percentage for payments |
|
8.98 | 30.57 | -70.62% |
|
|
| Difference from average difference in sector |
|
-11.21 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
26.24 | 80.84 | -67.54% | ||
| Growth impulse Ebitda in 5 years |
|
2.24 | 45.31 | -95.06% | ||
| Growth impulse Net Income in 5 years |
|
12.08 | 131.41 | -90.81% | ||
| Growth impulse FCF in 5 years |
|
-138.2 | 76.02 | -281.79% | ||
| Growth impulse EPS in 5 years |
|
12.08 | 286.48 | -95.78% |
IP Score
4.45/10
